Electromed (ELMD) Competitors

Electromed (NYSE:ELMD) and Iradimed (NASDAQ:IRMD) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk.

Do institutionals and insiders hold more shares of ELMD or IRMD?

40.8% of Electromed shares are held by institutional investors. Comparatively, 92.3% of Iradimed shares are held by institutional investors. 14.0% of Electromed shares are held by insiders. Comparatively, 36.8% of Iradimed shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Which has stronger earnings and valuation, ELMD or IRMD?

Iradimed has higher revenue and earnings than Electromed. Electromed is trading at a lower price-to-earnings ratio than Iradimed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Electromed	$61.44M	2.80	$5.15M	$0.79	25.96
Iradimed	$75.15M	9.75	$19.23M	$1.55	37.16

Do analysts recommend ELMD or IRMD?

Electromed currently has a consensus target price of $38.00, suggesting a potential upside of 85.28%. Iradimed has a consensus target price of $72.00, suggesting a potential upside of 25.00%. Given Electromed's stronger consensus rating and higher possible upside, equities research analysts plainly believe Electromed is more favorable than Iradimed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Electromed	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00
Iradimed	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more risk & volatility, ELMD or IRMD?

Electromed has a beta of 0.46, indicating that its stock price is 54% less volatile than the S&P 500. Comparatively, Iradimed has a beta of 0.91, indicating that its stock price is 9% less volatile than the S&P 500.

Does the media refer more to ELMD or IRMD?

In the previous week, Electromed had 1 more articles in the media than Iradimed. MarketBeat recorded 4 mentions for Electromed and 3 mentions for Iradimed. Iradimed's average media sentiment score of 1.84 beat Electromed's score of 1.44 indicating that Iradimed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Electromed	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Iradimed	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Does the MarketBeat Community believe in ELMD or IRMD?

Iradimed received 236 more outperform votes than Electromed when rated by MarketBeat users. However, 92.59% of users gave Electromed an outperform vote while only 65.58% of users gave Iradimed an outperform vote.

Company	Underperform	Outperform
Electromed	Outperform Votes 25 92.59%	Underperform Votes 2 7.41%
Iradimed	Outperform Votes 261 65.58%	Underperform Votes 137 34.42%

Is ELMD or IRMD more profitable?

Iradimed has a net margin of 26.26% compared to Electromed's net margin of 11.34%. Iradimed's return on equity of 24.12% beat Electromed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Electromed	11.34%	15.71%	13.37%
Iradimed	26.26%	24.12%	21.20%

Summary

Iradimed beats Electromed on 14 of the 19 factors compared between the two stocks.